Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Genetics of hepatocellular tumors

Abstract

Numerous genetic alterations are accumulated during the process of hepatocarcinogenesis. These genetic alterations can be divided into two groups. The first set of genetic alterations is specific of hepatocellular tumor risk factors. It includes integration of hepatitis B virus (HBV) DNA, R249S TP53 (tumor protein p53) mutation in aflatoxin B1-exposed patients, KRAS mutations related to vinyl chloride exposure, hepatocyte nuclear factor 1α (HNF1α) mutations associated to hepatocellular adenomas and adenomatosis polyposis coli (APC) germline mutations predisposing to hepatoblastomas. The second set of genetic alterations are etiological nonspecific, it includes recurrent gains and losses of chromosomes, alteration of TP53 gene, activation of WNT/β-catenin pathway through CTNNB1/β-catenin and AXIN (axis inhibition protein) mutations, inactivation of retinoblastoma and IGF2R (insulin-like growth factor 2 receptor) pathways through inactivation of RB1 (retinoblastoma 1), P16 and IGF2R. Comprehensive analyses of these genetic alterations have defined two pathways of hepatocarcinogenesis according to the presence or the absence of chromosomal instability. Hepatitis B virus and poorly differentiated tumors are related to chromosome instable tumors associated with frequent TP53 mutations, whereas non-HBV and well-differentiated tumors are related to chromosomal stable samples that are frequently β-catenin activated. These classifications have clinical relevance as genetic alterations may also be related to prognosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Andrisani OM, Barnabas S . (1999). Int J Oncol 15: 373–379.

  • Aoki H, Kajino K, Arakawa Y, Hino O . (1996). Proc Natl Acad Sci USA 93: 7300–7304.

  • Bacq T, Jacquemin E, Balabaud C, Jeannot E, Scotto B, Branchereau S et al. (2003). Gastroenterology 125: 1470–1475.

  • Balsara BR, Pei J, De Rienzo A, Simon D, Tosolini A, Lu YY et al. (2001). Gene Chromosome Cancer 30: 245–253.

  • Baumhueter S, Mendel DB, Conley PB, Kuo CJ, Turk C, Graves MK et al. (1990). Genes Dev 4: 372–379.

  • Biden K, Young J, Buttenshaw R, Searle J, Cooksley G, Xu DB et al. (1997). Hepatology 25: 593–597.

  • Bluteau O, Beaudoin J-C, Pasturaud P, Belghiti J, Franco D, Bioulac-Sage P et al. (2002a). Oncogene 21: 1225–1232.

  • Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H et al. (2002b). Nat Genet 32: 312–315.

  • Boige V, Laurent-Puig P, Fouchet P, Flejou JF, Monges G, Bedossa P et al. (1997). Cancer Res 57: 1986–1990.

  • Bressac B, Kew M, Wands J, Ozturk M . (1991). Nature 350: 429–431.

  • Buendia MA . (2002). Med Pediatr Oncol 39: 530–535.

  • Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD et al. (1998). Nature 392: 300–303.

  • Cai RL, Meng W, Lu HY, Lin WY, Jiang F, Shen FM . (2003). World J Gastroenterol 9: 2428–2432.

  • Cereghini S, Yaniv M, Cortese R . (1990). EMBO J 9: 2257–2263.

  • Cetta F, Mazzarella L, Bon G, Zuckermann M, Casorelli A, Nounga H . (2003). Med Pediatr Oncol 41: 496–497.

  • Chen YW, Jeng YM, Yeh SH, Chen PJ . (2002). Hepatology 36: 927–935.

  • Chiu JH, Kao HL, Wu LH, Chang HM, Lui WY . (1992). J Clin Invest 89: 539–545.

  • Chouard T, Blumenfeld M, Bach I, Vandekerckhove J, Cereghini S, Yaniv M . (1990). Nucleic Acids Res 18: 5853–5863.

  • Collonge-Rame MA, Bresson-Hadni S, Koch S, Carbillet JP, Blagosklonova O, Mantion G et al. (2001). Cancer Genet Cytogenet 127: 49–52.

  • de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O et al. (1998). Proc Natl Acad Sci USA 95: 8847–8851.

  • De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL . (1995). Nat Genet 11: 447–449.

  • Dejean A, Bougueleret L, Grzeschik KH, Tiollais P . (1986). Nature 322: 70–72.

  • Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA et al. (2001). J Biol Chem 276: 8328–8340.

  • Edmondson HA, Henderson B, Benton B . (1976). N Engl J Med 294: 470–472.

  • Edmondson HA, Peters RL . (1983). Semin Roentgenol 18: 75–83.

  • Essigmann JM, Croy RG, Nadzan AM, Busby Jr WF, Reinhold VN, Buchi G et al. (1977). Proc Natl Acad Sci USA 74: 1870–1874.

  • Ezaki T, Kanematsu T, Okamura T, Sonoda T, Sugimachi K . (1988). Cancer 61: 106–109.

  • Feitelson MA, Zhu M, Duan LX, London WT . (1993). Oncogene 8: 1109–1117.

  • Ferber MJ, Montoya DP, Yu C, Aderca I, McGee A, Thorland EC et al. (2003). Oncogene 22: 3813–3820.

  • Filson AJ, Louvi A, Efstratiadis A, Robertson EJ . (1993). Development 118: 731–736.

  • Frain M, Swart G, Monaci P, Nicosia A, Stampfli S, Frank R et al. (1989). Cell 59: 145–157.

  • Fujimoto J, Okamoto E, Yamanaka N, Toyosaka A, Mitsunobu M . (1991). Cancer 67: 939–944.

  • Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS . (1994). Cancer Res 54: 281–285.

  • Furuya K, Nakamura M, Yamamoto Y, Togei K, Otsuka H . (1988). Cancer 61: 99–105.

  • Graef E, Caselmann WH, Wells J, Koshy R . (1994). Oncogene 9: 81–87.

  • Groopman JD, Croy RG, Wogan GN . (1981). Proc Natl Acad Sci USA 78: 5445–5449.

  • Guan XY, Fang Y, Sham JS, Kwong DL, Zhang Y, Liang Q et al. (2000). Gene Chromosome Cancer 29: 110–116.

  • Hickman ES, Moroni MC, Helin K . (2002). Curr Opin Genet Dev 12: 60–66.

  • Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T et al. (2000). Nat Med 6: 96–99.

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC . (1991). Science 253: 49–53.

  • Horikawa I, Barrett JC . (2003). Carcinogenesis 24: 1167–1176.

  • Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, Peng SY . (2000). Am J Pathol 157: 763–770.

  • Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC . (1991). Nature 350: 427–428.

  • Huang H, Fujii H, Sankila A, Mahler-Araujo BM, Matsuda M, Cathomas G et al. (1999). Am J Pathol 155: 1795–1801.

  • Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T et al. (2004). Int J Oncol 24: 1077–1083.

  • Isobe M, Emanuel BS, Givol D, Oren M, Croce CM . (1986). Nature 320: 84–85.

  • Jin M, Piao Z, Kim NG, Park C, Shin EC, Park JH et al. (2000). Cancer 89: 60–68.

  • Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T . (1999). Cancer Res 59: 269–273.

  • Koch A, Weber N, Waha A, Hartmann W, Denkhaus D, Behrens J et al. (2004). J Pathol 204: 546–554.

  • Kondo Y, Kanai Y, Sakamoto M, Genda T, Mizokami M, Ueda R et al. (1999). Jpn J Cancer Res 90: 1301–1309.

  • Koyama M, Nagai H, Bando K, Ito M, Moriyama Y, Emi M . (1999). Jpn J Cancer Res 90: 951–956.

  • Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T et al. (1995). Gene Chromosome Cancer 13: 163–167.

  • Lagna G, Hata A, Hemmati-Brivanlou A, Massague J . (1996). Nature 383: 832–836.

  • Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F et al. (2001). Gastroenterology 120: 1763–1773.

  • Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW et al. (2005). Oncogene 24: 1477–1480.

  • Legoix P, Bluteau O, Bayer J, Perret C, Balabaud C, Belghiti J et al. (1999). Oncogene 18: 4044–4046.

  • Liew CT, Li HM, Lo KW, Leow CK, Chan JY, Hin LY et al. (1999). Oncogene 18: 789–795.

  • Lin Y, Shi CY, Li B, Soo BH, Mohammed-Ali S, Wee A et al. (1996). Ann Acad Med Singapore 25: 22–30.

  • Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM et al. (1996). Nature 381: 620–623.

  • Malkin D, Li FP, Strong LC, Fraumeni Jr JF, Nelson CE, Kim DH et al. (1990). Science 250: 1233–1238.

  • Mao TL, Chu JS, Jeng YM, Lai PL, Hsu HC . (2001). J Pathol 193: 95–101.

  • Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A et al. (1997). Gene Chromosome Cancer 18: 59–65.

  • Marchio A, Pineau P, Meddeb M, Terris B, Tiollais P, Bernheim A et al. (2000). Oncogene 19: 3733–3738.

  • Martin CN, Garner RC . (1977). Nature 267: 863–865.

  • Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H . (1999). Gastroenterology 116: 394–400.

  • McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T et al. (1995). Proc Natl Acad Sci USA 92: 2384–2387.

  • Miller C, Mohandas T, Wolf D, Prokocimer M, Rotter V, Koeffler HP . (1986). Nature 319: 783–784.

  • Miller EC . (1978). Cancer Res 38: 1479–1496.

  • Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S et al. (1998). Cancer Res 58: 2524–2527.

  • Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al. (1997). Science 275: 1787–1790.

  • Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, Hobman M et al. (2000). Cell 103: 491–500.

  • Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A . (1997). Oncogene 14: 2927–2933.

  • Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES, Buendia MA . (1999). Am J Pathol 155: 703–710.

  • Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K et al. (1992). Int J Cancer 51: 862–868.

  • Nishimura T, Nishida N, Itoh T, Kuno M, Minata M, Komeda T et al. (2002). Gene Chromosome Cancer 35: 329–339.

  • Oka Y, Waterland RA, Killian JK, Nolan CM, Jang HS, Tohara K et al. (2002). Hepatology 35: 1153–1163.

  • Okabe H, Ikai I, Matsuo K, Satoh S, Momoi H, Kamikawa T et al. (2000). Hepatology 31: 1073–1079.

  • Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y et al. (2001). Cancer Res 61: 2129–2137.

  • Paradis V, Laurendeau I, Vidaud M, Bedossa P . (1998). Hepatology 28: 953–958.

  • Paterlini-Brechot P, Saigo K, Murakami Y, Chami M, Gozuacik D, Mugnier C et al. (2003). Oncogene 22: 3911–3916.

  • Piao Z, Kim NG, Kim H, Park C . (1999). Cancer Lett 138: 227–232.

  • Piao Z, Park C, Park JH, Kim H . (1998). Int J Cancer 75: 29–33.

  • Piao Z, Park YN, Kim H, Park C . (1997). Liver 17: 251–256.

  • Pineau P, Nagai H, Prigent S, Wei Y, Gyapay G, Weissenbach J et al. (1999). Oncogene 18: 3127–3134.

  • Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T et al. (2000). Nat Genet 24: 245–250.

  • Shen FM, Lee MK, Gong HM, Cai XQ, King MC . (1991). Am J Hum Genet 49: 88–93.

  • Shirota Y, Kaneko S, Honda M, Kawai HF, Kobayashi K . (2001). Hepatology 33: 832–840.

  • Smela ME, Currier SS, Bailey EA, Essigmann JM . (2001). Carcinogenesis 22: 535–545.

  • Sun CA, Wang LY, Chen CJ, Lu SN, You SL, Wang LW et al. (2001). Carcinogenesis 22: 1289–1294.

  • Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K . (1993). Cancer Res 53: 2884–2887.

  • Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM et al. (2002). Oncogene 21: 4863–4871.

  • Terada T, Ueda K, Nakanuma Y . (1993). Virchows Arch A 422: 381–388.

  • Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S . (1994). Cancer Res 54: 231–235.

  • Terris B, Pineau P, Bregeaud L, Valla D, Belghiti J, Tiollais P et al. (1999). Oncogene 18: 6583–6588.

  • Thomas RM, Berman JJ, Yetter RA, Moore GW, Hutchins GM . (1992). Hum Pathol 23: 496–503.

  • Tsuda H, Zhang WD, Shimosato Y, Yokota J, Terada M, Sugimura T et al. (1990). Proc Natl Acad Sci USA 87: 6791–6794.

  • Vautier G, Bomford AB, Portmann BC, Metivier E, Williams R, Ryder SD . (1999). Gastroenterology 117: 154–160.

  • Wang J, Chenivesse X, Henglein B, Brechot C . (1990). Nature 343: 555–557.

  • Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA . (2000). Oncogene 19: 498–504.

  • Weihrauch M, Benicke M, Lehnert G, Wittekind C, Wrbitzky R, Tannapfel A . (2001). Br J Cancer 84: 982–989.

  • Weinberg AG, Finegold MJ . (1983). Hum Pathol 14: 512–537.

  • Wong CM, Fan ST, Ng IO . (2001). Cancer 92: 136–145.

  • Wong N, Lai P, Pang E, Leung TW, Lau JW, Johnson PJ . (2000). Hepatology 32: 1060–1068.

  • Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q et al. (2001). Proc Natl Acad Sci USA 98: 15089–15094.

  • Yakicier MC, Irmak MB, Romano A, Kew M, Ozturk M . (1999). Oncogene 18: 4879–4883.

  • Yakicier Y, Legoix P, Vaury C, Gressin L, Tubacher E, Capron F et al. (2001). Oncogene 20: 5232–5238.

  • Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M et al. (1996). Nature 384: 455–458.

  • Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT et al. (2001). Gastroenterology 121: 699–709.

  • Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE et al. (2001). Nat Genet 28: 29–35.

  • Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, Liu CJ et al. (2000). J Natl Cancer Inst 92: 1159–1164.

  • Zhang X, Xu HJ, Murakami Y, Sachse R, Yashima K, Hirohashi S et al. (1994). Cancer Res 54: 4177–4182.

  • Zucman-Rossi J, Jeannot E, Tran Van Nhieu J, Scoazec J-Y, Guettier C, Rebouissou S et al. (2006). Hepatology 43: 515–524.

Download references

Acknowledgements

This work was supported by the Inserm and the Fondation de France.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Zucman-Rossi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laurent-Puig, P., Zucman-Rossi, J. Genetics of hepatocellular tumors. Oncogene 25, 3778–3786 (2006). https://doi.org/10.1038/sj.onc.1209547

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209547

Keywords

This article is cited by

Search

Quick links